South-East Asia Rheumatoid Arthritis Therapeutics Market 2022 South-East Asia Rheumatoid Arthritis Therapeutics | Page 4

- Compare treatment usage patterns, annual therapy costs, and market growth projections for
South Korea, Singapore, Taiwan, Malaysia, the Philippines, Thailand, Vietnam, and Indonesia.
- Discover trends in licensing and co-development deals concerning RA products and identify the
major strategic consolidations that have shaped the commercial landscape.
Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 8
Access Full Report With TOC @ http://www.radiantinsights.com/research/rheumatoid-
arthritis-therapeutics-in-south-east-asia-markets-to-2022
2 Introduction 10
2.1 Disease Introduction 10
2.2 Epidemiology 11
2.3 Symptoms 11
2.4 Etiology and Pathophysiology 11
2.5 Diagnosis 13
2.5.1 Physical Examination 13
2.5.2 Blood Tests 13
2.5.3 1987 Rheumatoid Arthritis Classification 14
2.5.4 2010 ACR-EULAR Classification Criteria for Rheumatoid Arthritis 14
2.6 Prognosis 14
2.7 Treatment Guidelines and Options 15
2.7.1 Pharmacological 16
2.7.2 Methotrexate 16
2.7.3 Hydroxychloroquine 17
2.7.4 Leflunomide 17
Follow Us: